The european Commission has signed, on Tuesday, its first contract to supply medical against the Covid-19 and this is the remdesivir wins to 63 million euros of order. The controversial French between hydroxychloroquine, promoted by professor Didier Raoult, and the remdesivir, was not known in Europe and the impact that it has had in France. The remdesivir, laboratories Gilead, is the only registered treatment for a month against the Covid-19 at european level. Hydroxychloroquine, preferred by Didier Raoult, has not been approved at this stage.
The first contract for the gara...
Article reserved to subscribersAlready a subscriber ?
Not a subscriber yet ?
Subscribe Date Of Update: 29 July 2020, 11:33
